Exclusive-China in talks with Pfizer for generic COVID drug - sources

China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the U.S. firm's COVID-19 antiviral drug Paxlovid in... | January 6, 2023

Related Keywords

Beijing ,China ,New York ,United States ,Huahai ,Gansu ,Hong Kong ,Chinese ,Sumeet Chatterjee ,Jacqueline Wong ,Julie Zhu ,Kevin Huang ,Pfizer ,Council Information Office ,World Health Organization ,National Medical Products Administration ,Public Health Emergency Of International Concern ,Reuters ,Lunar New Year ,State Council Information Office ,Huahai Pharmaceutical ,Medicines Patent Pool ,Health Emergency ,Michael Erman ,Cspc Pharmaceutical Group Ltd Stock Exchange ,News ,Information ,Press Release ,Us ,N ,Talks ,Ith ,Nc ,O ,Ecure ,Licence ,Hat ,Hill ,Follow ,Domestic ,Drugmakers ,Manufacture ,End ,Istribute ,Generic ,Version ,F ,The ,Antiviral ,Drug ,Axlovid 1093 Hk1093012172 ,